 |
 |
 |
 |
Journal articles
Defective ubiquitin-mediated degradation of antiapoptotic Bfl-1 predisposes to lymphoma
Abstract : The antiapoptotic Bcl-2 family member Bfl-1 is up-regulated in many human tumors in which nuclear factor-κB (NF-κB) is implicated and contributes significantly to tumor cell survival and chemoresistance. We previously found that NF-κB induces transcription of bfl-1 and that the Bfl-1 protein is also regulated by ubiquitin-mediated proteasomal degradation. However, the role that dysregulation of Bfl-1 turnover plays in cancer is not known. Here we show that ubiquitination-resistant mutants of Bfl-1 display increased stability and greatly accelerated tumor formation in a mouse model of leukemia/lymphoma. We also show that tyrosine kinase Lck is up-regulated and activated in these tumors and leads to activation of the IkappaB kinase, Akt, and extracellular signal-regulated protein kinase signaling pathways, which are key mediators in cancer. Coexpression of Bfl-1 and constitutively active Lck promoted tumor formation, whereas Lck knockdown in tumor-derived cells suppressed leukemia/lymphomagenesis. These data demonstrate that ubiquitination is a critical tumor suppression mechanism regulating Bfl-1 function and suggest that mutations in bfl-1 or in the signaling pathways that control its ubiquitination may predispose one to cancer. Furthermore, because bfl-1 is up-regulated in many human hematopoietic tumors, this finding suggests that strategies to promote Bfl-1 ubiquitination may improve therapy.
https://hal-ens-lyon.archives-ouvertes.fr/ensl-00815695
Contributor : Agnès Ganivet Connect in order to contact the contributor
Submitted on : Friday, April 19, 2013 - 11:14:56 AM
Last modification on : Wednesday, November 20, 2019 - 7:59:32 AM
Contributor : Agnès Ganivet Connect in order to contact the contributor
Submitted on : Friday, April 19, 2013 - 11:14:56 AM
Last modification on : Wednesday, November 20, 2019 - 7:59:32 AM